MARKET

KPTIQ

KPTIQ

Karyopharm Therapeutics Inc
OTCPK
0.020
+0.002
+12.07%
Closed 15:57 11/11 EST
OPEN
0.0081
PREV CLOSE
0.017
HIGH
0.020
LOW
0.0080
VOLUME
4.90M
TURNOVER
59.91K
52 WEEK HIGH
10.99
52 WEEK LOW
0.0080
MARKET CAP
442.29K
P/E (TTM)
-0.0015
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 1d ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 1d ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 1d ago
Why Sanmina Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
Benzinga · 1d ago
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 2d ago
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 2d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 2d ago
Why Greenfire Resources Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket
Benzinga · 2d ago
More
About KPTIQ
Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company. The Company is engaged in the discovery, development and commercialization of drugs directed against nuclear export for the treatment of cancer. It is developing and commercializing novel, small molecule XPO1 inhibitor compounds that inhibit the nuclear export protein exportin 1 (XPO1). Its lead asset, XPOVIO (selinexor), is marketed in combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy. XPOVIO is also marketed for treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). The Company is engaged in evaluating selinexor in certain hematological and solid tumor malignancies, including myelofibrosis, endometrial cancer and multiple myeloma. The Company’s product candidate, eltanexor, is an oral SINE compound like selinexor, that selectively blocks the nuclear export protein XPO1.

Webull offers Karyopharm Therapeutics Inc stock information, including OTCPK: KPTIQ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KPTIQ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KPTIQ stock methods without spending real money on the virtual paper trading platform.